{"id":"omega-3-treatment","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Gastrointestinal upset (nausea, dyspepsia, diarrhea)"},{"rate":"5-10","effect":"Fishy aftertaste or odor"},{"rate":"1-3","effect":"Bleeding or bruising (at high doses)"},{"rate":"1-2","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL3137327","moleculeType":"Unknown","molecularWeight":"2750.26"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Omega-3 polyunsaturated fatty acids (EPA and DHA) decrease triglyceride levels, reduce platelet aggregation, and lower inflammatory markers including C-reactive protein and cytokines. They also improve endothelial function and may stabilize atherosclerotic plaques, reducing cardiovascular events in at-risk populations.","oneSentence":"Omega-3 fatty acids reduce inflammation and modulate lipid metabolism to improve cardiovascular and metabolic outcomes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:24:11.385Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertriglyceridemia"},{"name":"Secondary prevention of cardiovascular disease"},{"name":"Reduction of cardiovascular events in high-risk patients"}]},"trialDetails":[{"nctId":"NCT06195306","phase":"PHASE2","title":"Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-07-28","conditions":"Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ","enrollment":66},{"nctId":"NCT05181189","phase":"PHASE2","title":"NMDA Enhancement Combined With Omega-3 for Early Dementia","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-08","conditions":"Omega 3 Fatty Acids, Dementia","enrollment":140},{"nctId":"NCT03911414","phase":"PHASE4","title":"A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-06-18","conditions":"Mood Disturbance, Mood Disorders, Natural Supplements","enrollment":27},{"nctId":"NCT07461649","phase":"NA","title":"Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Credit Pharmaceutical Co., Ltd.","startDate":"2026-03-15","conditions":"Bioavailability and Pharmacokinetics","enrollment":32},{"nctId":"NCT05297279","phase":"NA","title":"OMEGA - Dietary Intervention - COPD Trial","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-03-01","conditions":"COPD, Chronic Obstructive Pulmonary Disease","enrollment":200},{"nctId":"NCT07470892","phase":"","title":"Preoperative Fish Oil PN and Prognosis After Constipation Surgery","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2026-03","conditions":"Constipation, Slow Transit Constipation, Megacolon","enrollment":306},{"nctId":"NCT05145452","phase":"NA","title":"n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy","status":"TERMINATED","sponsor":"University of Missouri-Columbia","startDate":"2021-01-14","conditions":"Diabetic Neuropathies","enrollment":31},{"nctId":"NCT07462013","phase":"NA","title":"NUTRIBRAIN: Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice (POWER)","status":"RECRUITING","sponsor":"National Science and Technology Council, Taiwan","startDate":"2025-10-01","conditions":"Major Depressive Disorder (MDD)","enrollment":120},{"nctId":"NCT07173166","phase":"NA","title":"Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy","status":"RECRUITING","sponsor":"Instituto de Investigacion Sanitaria INCLIVA","startDate":"2025-09-30","conditions":"Hematologic Cancer","enrollment":100},{"nctId":"NCT06123286","phase":"EARLY_PHASE1","title":"Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms","status":"RECRUITING","sponsor":"Philip Chang","startDate":"2025-09-12","conditions":"Breast Cancer, Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain","enrollment":30},{"nctId":"NCT02653092","phase":"NA","title":"Reprometabolic Syndrome Mediates Subfertility in Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2016-06","conditions":"Obesity, Infertility, Hypogonadotropic Hypogonadotropism","enrollment":84},{"nctId":"NCT07439744","phase":"NA","title":"NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status","status":"RECRUITING","sponsor":"National Science and Technology Council, Taiwan","startDate":"2025-03-01","conditions":"Obese Adults, MDD","enrollment":50},{"nctId":"NCT06279793","phase":"PHASE2","title":"Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients","status":"RECRUITING","sponsor":"GCP-Service International West GmbH","startDate":"2024-02-15","conditions":"Intensive Care Unit, Coronary Artery Bypass Grafting (CABG), High Risk Patients","enrollment":550},{"nctId":"NCT06991296","phase":"NA","title":"Concentration of n-3 PUFA Monohydroxylated Derivatives in Adults With Obesity After n-3 PUFA Supplementation.","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-06-02","conditions":"Obesity","enrollment":33},{"nctId":"NCT05774665","phase":"PHASE2","title":"Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-01-30","conditions":"Treatment Resistant Depression, Inflammation, Overweight","enrollment":80},{"nctId":"NCT07399743","phase":"PHASE3","title":"Effects of Lower Body Positive Pressure Therapy Versus Alpha Lipoic Acid and Omega-3 Fatty Acids on Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"Badr University","startDate":"2026-02-15","conditions":"Knee Osteoarthritis","enrollment":160},{"nctId":"NCT07385300","phase":"NA","title":"Omega-3 Pufa and Aspirin as Adjunctive Therapy in Treatment of Smoker Patients With Stage Iii Periodontitis","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-08-20","conditions":"Periodontitis, Diabete Mellitus","enrollment":45},{"nctId":"NCT07371416","phase":"NA","title":"Regenerative Root Canal Treatment of Immature Teeth Using Omega-3 Fatty Acids","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mansoura University","startDate":"2025-10-01","conditions":"Immature Permanent Teeth With Open Apex, Pulp Necrosis","enrollment":20},{"nctId":"NCT07352618","phase":"NA","title":"\"Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus.\"","status":"ENROLLING_BY_INVITATION","sponsor":"Bangladesh Medical University","startDate":"2026-01","conditions":"Type2 Diabetes Mellitus","enrollment":66},{"nctId":"NCT07346703","phase":"NA","title":"Effects of DHA in Patients With Multiple Sclerosis","status":"ENROLLING_BY_INVITATION","sponsor":"Francisco Javier Martínez Noguera","startDate":"2026-01","conditions":"Multiple Sclerosis, Performance Enhancement, Supplemental Nutrition Assistance Program Education","enrollment":100},{"nctId":"NCT07288619","phase":"NA","title":"Therapeutic Efficacy of Nutritional Supplementation in Cachexia Associated With Chronic Pulmonary Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Safeer Khan","startDate":"2025-10-15","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Cachexia","enrollment":45},{"nctId":"NCT07304921","phase":"PHASE1","title":"Novel Approach to Increase EPA and DHA Levels","status":"COMPLETED","sponsor":"Riga Stradins University","startDate":"2023-04-06","conditions":"Lipid Metabolism, Omega-3 Polyunsaturated Fatty Acids, Supplementation","enrollment":48},{"nctId":"NCT03753334","phase":"PHASE2","title":"Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.","status":"ACTIVE_NOT_RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2017-07-10","conditions":"Prostate Cancer","enrollment":39},{"nctId":"NCT07226414","phase":"NA","title":"Prenatal Study in Healthy Pregnant Women","status":"RECRUITING","sponsor":"Perelel Inc.","startDate":"2025-12-01","conditions":"Pregnancy","enrollment":40},{"nctId":"NCT06751810","phase":"NA","title":"Nutritional Status in Children With Food Allergy: Evaluation of a New Supplement","status":"COMPLETED","sponsor":"Federico II University","startDate":"2024-12-30","conditions":"Food Allergies","enrollment":30},{"nctId":"NCT07289919","phase":"NA","title":"Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower Oils","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-05-26","conditions":"Cardiovascular (CV) Risk, Atheroscleroses, Inflamation","enrollment":15},{"nctId":"NCT07078344","phase":"PHASE2","title":"Omega-3D: Omega-3 for Diet-Driven Health Disparities","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2025-07-31","conditions":"Heart Health Markers, Cardiovascular Diseases, Omega 3 Fatty Acids","enrollment":200},{"nctId":"NCT02445651","phase":"NA","title":"Physiological Effects of Nutritional Support in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2014-03","conditions":"Parkinson Disease, Idiopathic Parkinson Disease","enrollment":51},{"nctId":"NCT06654063","phase":"NA","title":"Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis Patients","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-04-01","conditions":"Vitamin D Deficiency","enrollment":72},{"nctId":"NCT06695910","phase":"PHASE4","title":"Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).","status":"RECRUITING","sponsor":"Samuel Fortin","startDate":"2024-11-06","conditions":"Brain Fog, Cognitive Health","enrollment":48},{"nctId":"NCT07272382","phase":"NA","title":"Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-06-05","conditions":"Esophageal Neoplasms","enrollment":142},{"nctId":"NCT07038252","phase":"NA","title":"The Effect of Oral SPM Supplementation on INflammation-induced Vascular Ageing in Obese Hypertensive Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-11-26","conditions":"Hypertension, Obesity","enrollment":50},{"nctId":"NCT06545721","phase":"NA","title":"Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-08-13","conditions":"Polycystic Ovary Syndrome","enrollment":425},{"nctId":"NCT07055620","phase":"NA","title":"Effects of Different Dietary Models on Eating Behavior and Obesity Management in Overweight and Obese Individuals","status":"COMPLETED","sponsor":"Selcuk University","startDate":"2025-04-18","conditions":"Mediterranean Diet, Intermittent Fasting, Diet","enrollment":75},{"nctId":"NCT06055894","phase":"NA","title":"A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-09-20","conditions":"Multiple Myeloma, Smoldering, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance","enrollment":200},{"nctId":"NCT00244816","phase":"PHASE2","title":"Taxoprexin® Treatment for Advanced Eye Melanoma","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-10","conditions":"Metastatic Melanoma","enrollment":22},{"nctId":"NCT00422877","phase":"PHASE2","title":"Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract","status":"TERMINATED","sponsor":"American Regent, Inc.","startDate":"2007-01","conditions":"Cancer of the Liver","enrollment":13},{"nctId":"NCT05198843","phase":"PHASE1, PHASE2","title":"Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2022-11-08","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Inflammatory Carcinoma","enrollment":1},{"nctId":"NCT07085923","phase":"NA","title":"Norwegian Mental Illness Heart Health Study","status":"RECRUITING","sponsor":"Madeleine Elisabeth Angelsen","startDate":"2025-09-16","conditions":"Cardio Vascular Disease, Metabolic Syndrome (MetS), Severe Mental Disorder","enrollment":70},{"nctId":"NCT00249262","phase":"PHASE2","title":"Taxoprexin Treatment for Advanced Skin Melanoma","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-10","conditions":"Metastatic Melanoma","enrollment":30},{"nctId":"NCT03869957","phase":"NA","title":"Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2019-12-01","conditions":"Intestinal Failure","enrollment":20},{"nctId":"NCT04553705","phase":"PHASE2, PHASE3","title":"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2020-09-20","conditions":"Covid19, Immunodeficiency","enrollment":150},{"nctId":"NCT04152291","phase":"NA","title":"The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism","status":"COMPLETED","sponsor":"Wihuri Research Institute","startDate":"2019-11-12","conditions":"Atherosclerosis, Low-density Lipoproteins Aggregation Susceptibility, Low-density Lipoprotein Lipid Composition","enrollment":68},{"nctId":"NCT07182292","phase":"NA","title":"Effect of a Combined Exercise and Anti-Inflammatory Nutritional Intervention in Frail Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Miguel Servet","startDate":"2025-10-01","conditions":"Frail Elderly Syndrome, Malnutrition Elderly","enrollment":158},{"nctId":"NCT03406897","phase":"PHASE1, PHASE2","title":"Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients","status":"COMPLETED","sponsor":"Rodolfo Alejandro","startDate":"2018-07-23","conditions":"Diabetes Mellitus, Type 1, Hypoglycemia, Diabetes Mellitus","enrollment":27},{"nctId":"NCT02295059","phase":"NA","title":"Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2017-08-09","conditions":"Breast Cancer","enrollment":80},{"nctId":"NCT05007483","phase":"NA","title":"Efficacy of Diet on Quality of Life in Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Terry L. Wahls","startDate":"2022-02-10","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":162},{"nctId":"NCT06971445","phase":"NA","title":"Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy","status":"ENROLLING_BY_INVITATION","sponsor":"Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes","startDate":"2025-05-14","conditions":"Pregnant HIV Positive Women","enrollment":92},{"nctId":"NCT04293874","phase":"NA","title":"Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer","status":"COMPLETED","sponsor":"University of Connecticut","startDate":"2018-04-11","conditions":"Fatigue, Depression, Pain","enrollment":98},{"nctId":"NCT07164014","phase":"NA","title":"The Impact of the Mediterranean Diet on Anthropometric Indices, Lipid Profiles, Energy Metabolism Signaling Proteins and Inflammatory Cytokines in Psychiatric Patients With Metabolic Syndrome","status":"COMPLETED","sponsor":"King Saud University","startDate":"2024-05-01","conditions":"Metabolic Syndrome (MetS), Psychiatric Disorders, Mediterranean Diet","enrollment":144},{"nctId":"NCT02330926","phase":"PHASE3","title":"Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2015-04","conditions":"Cachexia, Neoplasms","enrollment":221},{"nctId":"NCT06896201","phase":"NA","title":"Comfortage - AD Prevention Strategies","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-09","conditions":"Alzheimer Disease, Subjective Cognitive Impairment, Mild Cognitive Impairment","enrollment":200},{"nctId":"NCT02670161","phase":"PHASE4","title":"Quality Improvement and Practice Based Research in Neurology Using the EMR","status":"ENROLLING_BY_INVITATION","sponsor":"Endeavor Health","startDate":"2016-05","conditions":"Brain Tumors, Epilepsy, Migraine","enrollment":3300},{"nctId":"NCT07136519","phase":"PHASE2","title":"Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Guangdong Medical University","startDate":"2025-08-22","conditions":"Nasopharyngeal Carcinoma (NPC)","enrollment":30},{"nctId":"NCT07138131","phase":"NA","title":"Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia","status":"COMPLETED","sponsor":"Benha University","startDate":"2023-10-01","conditions":"Omega 3, Treatment, Inappropriate Sinus Tachycardia","enrollment":60},{"nctId":"NCT07118059","phase":"PHASE2","title":"Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial","status":"NOT_YET_RECRUITING","sponsor":"North-West University, South Africa","startDate":"2025-08","conditions":"Tuberculosis, Inflammation Biomarkers, Liver Function Tests","enrollment":40},{"nctId":"NCT07107087","phase":"NA","title":"A Cluster Randomised Controlled Trial of a Multimodal Integrated Intervention for Kidney Cachexia","status":"NOT_YET_RECRUITING","sponsor":"Queen's University, Belfast","startDate":"2025-08-01","conditions":"Cachexia, CKD","enrollment":40},{"nctId":"NCT00243867","phase":"PHASE3","title":"Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-11","conditions":"Non-Small Cell Lung Cancer","enrollment":518},{"nctId":"NCT03241732","phase":"NA","title":"PET-MRI in Chronic Traumatic Brain Injury (CTBI)","status":"ENROLLING_BY_INVITATION","sponsor":"Thomas Jefferson University","startDate":"2017-06-07","conditions":"Chronic Traumatic Brain Injury","enrollment":150},{"nctId":"NCT06832787","phase":"NA","title":"Evaluation of Combinational Use of Negative Pressure Wound Therapy (NPWT) for Diabetic Foot Wounds","status":"RECRUITING","sponsor":"Singapore General Hospital","startDate":"2025-07-22","conditions":"Diabetic Foot Ulcer","enrollment":75},{"nctId":"NCT07036952","phase":"NA","title":"Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.","status":"ENROLLING_BY_INVITATION","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2025-04-22","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":68},{"nctId":"NCT05169060","phase":"PHASE1, PHASE2","title":"Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of Iowa","startDate":"2023-06-12","conditions":"Diabetic Neuropathies","enrollment":100},{"nctId":"NCT07067515","phase":"PHASE1, PHASE2","title":"Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival Hyperpigmentation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez Canal University","startDate":"2024-01-03","conditions":"Hyperpigmentation, Gingival Hyperpigmentaion","enrollment":30},{"nctId":"NCT01248728","phase":"PHASE2","title":"Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG)","status":"COMPLETED","sponsor":"Holland Bloorview Kids Rehabilitation Hospital","startDate":"2010-11","conditions":"Autism Spectrum Disorder","enrollment":38},{"nctId":"NCT07056257","phase":"NA","title":"Adjunct Use of Diode Laser Therapy and Omega 3 Gel in Local Drug Delivery Approach on The Treatment of Localized Aggressive Periodontitis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-05-08","conditions":"Diode Laser Therapy, Omega 3, Localized Aggressive Periodontitis","enrollment":52},{"nctId":"NCT06630637","phase":"NA","title":"Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study","status":"COMPLETED","sponsor":"Institute for Digital Medicine (WisDM)","startDate":"2024-10-07","conditions":"Intermittent Fasting, Healthy, Digital Health","enrollment":1},{"nctId":"NCT07050524","phase":"PHASE2","title":"Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-09-01","conditions":"Gastric Cancer Stage III","enrollment":80},{"nctId":"NCT07042724","phase":"NA","title":"Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study","status":"RECRUITING","sponsor":"Universita di Verona","startDate":"2025-09-01","conditions":"Lung Cancer (NSCLC)","enrollment":324},{"nctId":"NCT03757585","phase":"PHASE4","title":"Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-05-20","conditions":"Non-verbal Learning Disorder, Autism Spectrum Disorder, Autism","enrollment":54},{"nctId":"NCT04645927","phase":"NA","title":"Clinical Trial to Study the Effects of Dietary Flax Beverage on Memory and Cognition","status":"COMPLETED","sponsor":"St. Boniface Hospital","startDate":"2020-10-09","conditions":"Memory; Disturbance, Mild","enrollment":19},{"nctId":"NCT05324475","phase":"NA","title":"Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition.","status":"RECRUITING","sponsor":"Patrizia D'Amelio","startDate":"2025-04-01","conditions":"Malnutrition, Sarcopenia","enrollment":240},{"nctId":"NCT02629497","phase":"EARLY_PHASE1","title":"Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2015-11","conditions":"Thrombosis, Type 2 Diabetes Mellitus","enrollment":90},{"nctId":"NCT06995586","phase":"NA","title":"Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.","status":"NOT_YET_RECRUITING","sponsor":"Nicosia General Hospital","startDate":"2025-09-01","conditions":"Cardio-pulmonary Bypass, Cardiovascular Diseases, Omega-3 Polyunsaturated Fatty Acids","enrollment":108},{"nctId":"NCT04513418","phase":"PHASE3","title":"Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy","status":"RECRUITING","sponsor":"Hecheng Li M.D., Ph.D","startDate":"2020-11-10","conditions":"Esophageal Neoplasms","enrollment":244},{"nctId":"NCT03110432","phase":"","title":"Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2017-05-18","conditions":"Dyslipoproteinemias, Hypercholesterolemia, Familial, Familial Hypercholesterolemia - Homozygous","enrollment":1695},{"nctId":"NCT06928701","phase":"NA","title":"Impact of \"Targeted\" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)","status":"RECRUITING","sponsor":"University of Eastern Piedmont","startDate":"2024-09-01","conditions":"Early Breast Cancer, Neoadjuvant Treatment","enrollment":160},{"nctId":"NCT06918080","phase":"PHASE4","title":"Hepatoprotective Measures for Children at High Risk of NAFLD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","startDate":"2023-11-19","conditions":"Non Alcoholic Fatty Liver Diseases (NAFLD), Obesity and Overweight, Acute Lymphoblastic Leukemia","enrollment":200},{"nctId":"NCT06918054","phase":"PHASE4","title":"Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2023-11-17","conditions":"Leukaemia (Acute), Acute Lymphoblastic Leukemia","enrollment":42},{"nctId":"NCT05573672","phase":"PHASE2","title":"Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder","status":"COMPLETED","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2022-08-12","conditions":"Generalized Anxiety Disorder","enrollment":50},{"nctId":"NCT02521753","phase":"NA","title":"Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients","status":"TERMINATED","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2015-08","conditions":"Polycystic Ovary Syndrome, Obesity","enrollment":123},{"nctId":"NCT05953064","phase":"NA","title":"Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2023-01-01","conditions":"Hypertriglyceridemia","enrollment":20},{"nctId":"NCT05621083","phase":"NA","title":"Omega-3 Fatty Acids on Fasting and Postprandial Triglycerides (TG) Response - a Pilot Study","status":"COMPLETED","sponsor":"University of Oslo","startDate":"2023-04-11","conditions":"Healthy","enrollment":34},{"nctId":"NCT05379712","phase":"PHASE2","title":"Nutritional Supplementation in Head and Neck Cancers","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2024-10-25","conditions":"Malnourishment, Nutritional Deficiency, Undernutrition","enrollment":81},{"nctId":"NCT01248130","phase":"PHASE2","title":"Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2009-11","conditions":"Autism Spectrum Disorder (ASD)","enrollment":7},{"nctId":"NCT06154408","phase":"NA","title":"Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms","status":"COMPLETED","sponsor":"S.LAB (SOLOWAYS)","startDate":"2022-02-10","conditions":"LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease","enrollment":102},{"nctId":"NCT06005454","phase":"NA","title":"The Impact of Fish Oil Supplementation on the Outcome of Children with Pneumonia I","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-09-01","conditions":"Pneumonia","enrollment":122},{"nctId":"NCT06863935","phase":"NA","title":"A Pilot Study of High-Dose Omega-3 (Soloways ™) Polyunsaturated Fatty Acids in Patients with Dyslipidemia Carrying FADS1/FADS2 Variants","status":"COMPLETED","sponsor":"S.LAB (SOLOWAYS)","startDate":"2024-05-10","conditions":"Dyslipidemia","enrollment":40},{"nctId":"NCT04116203","phase":"PHASE1","title":"Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2016-06-30","conditions":"Polycystic Ovary Syndrome, Lipid Metabolism Disorders","enrollment":52},{"nctId":"NCT02371460","phase":"PHASE3","title":"Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2015-06-23","conditions":"Bronchopulmonary Dysplasia, Child Development, Neonatal and Perinatal Conditions","enrollment":800},{"nctId":"NCT03169790","phase":"PHASE1, PHASE2","title":"QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Non Hodgkin Lymphoma","enrollment":""},{"nctId":"NCT03169764","phase":"PHASE1, PHASE2","title":"QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":""},{"nctId":"NCT03175666","phase":"PHASE1, PHASE2","title":"QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Triple Negative Breast Cancer","enrollment":""},{"nctId":"NCT03169777","phase":"PHASE1, PHASE2","title":"QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2018-08","conditions":"Colorectal Cancer","enrollment":""},{"nctId":"NCT03167177","phase":"PHASE1, PHASE2","title":"QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Melanoma","enrollment":""},{"nctId":"NCT03169738","phase":"PHASE1, PHASE2","title":"QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2018-02","conditions":"Non-small Cell Lung Cancer","enrollment":""},{"nctId":"NCT03197584","phase":"PHASE1, PHASE2","title":"QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Ovarian Cancer","enrollment":""},{"nctId":"NCT03197571","phase":"PHASE1, PHASE2","title":"QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Urothelial Carcinoma","enrollment":""},{"nctId":"NCT06840964","phase":"NA","title":"Effect of Omega 3 in Hypertensive Patients","status":"COMPLETED","sponsor":"Santa Maria de la Salud, Argentina","startDate":"2023-03-23","conditions":"Hypertension, Dyslipidemia","enrollment":100},{"nctId":"NCT03167164","phase":"PHASE1, PHASE2","title":"QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Merkel Cell Carcinoma","enrollment":""},{"nctId":"NCT00559156","phase":"PHASE2","title":"Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy","status":"COMPLETED","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2005-06","conditions":"Head and Neck Cancer","enrollment":46}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":57,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dietary intervention"],"phase":"phase_3","status":"active","brandName":"Omega-3 treatment","genericName":"Omega-3 treatment","companyName":"University Hospital, Toulouse","companyId":"university-hospital-toulouse","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Omega-3 fatty acids reduce inflammation and modulate lipid metabolism to improve cardiovascular and metabolic outcomes. Used for Hypertriglyceridemia, Secondary prevention of cardiovascular disease, Reduction of cardiovascular events in high-risk patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":10,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}